Close Alert

Return to Campus Update

Coronavirus (COVID-19): The latest updates about USciences return to campus: usciences.edu/coronavirus. The full plan for a phased return of employees and students: usciences.edu/campusguidelines.

2020-2021 Board of Trustees

James J. RivardJames J. Rivard, P’81, MBA
Board Chair
Board Member Since 2014
BS, Philadelphia College of Pharmacy; MBA, University of New Hampshire
Retired Senior Vice President, Virtua Health 

Rivard retired from a career at Virtua Health where he served as Senior Vice President of Support Services where he was accountable for supply chain, capital acquisition and facility development. He has overseen $1 billion in capital projects and construction projects across the Virtua organization. Prior to this role, Rivard held several leadership positions in Virtua including, Assistant Vice President for clinical resource management, Assistant Vice President for hospital affairs, Director of Ancillary Clinical Services and Director of Pharmacy at Camden Hospital. Prior to Virtua, Rivard worked as a pharmacist at Cooper Hospital, Caremark Homecare, NMC Homecare, and Hampton Hospital


Michael C. HemsleyMichael C. Hemsley, Esq.
Vice Chair
Board Member Since 2016
BS, St. Joseph’s University; MA, The George Washington University; JD, Villanova University School of Law
Retired Deputy General Counsel, Trinity Health

Hemsley last served as deputy general counsel for Trinity Health, one of the largest health systems in the United States, focusing on mergers and regulatory matters. Prior to its 2014 merger into Trinity, Hemsley served as executive vice president and general counsel for Catholic Health East ("CHE"), a healthcare system operating in 11 states for several years, also serving as CHE's system corporate compliance officer, providing oversight and guidance to compliance officers and boards across its regional subsidiaries. Prior to joining CHE, Hemsley spent more than 20 years in private practice, last as a partner and chair of the health law department at Wolf, Block, LLP. Hemsley is a member of the American Health Lawyers Association, the Pennsylvania Bar Association, and the District of Columbia Bar Association. A certified healthcare compliance professional, Hemsley is a member of the Health Care Compliance Association, where he served as a board member and officer. A lecturer and author, he was a principal drafter of Corporate Responsibility and Corporate Compliance: A Resource for Health Care Boards of Directors and two subsequent Healthcare Board Educational Resource publications, each sponsored by the American Health Lawyers Association and the Office of Inspector General of the U.S. Department of Health and Human Services. Hemsley also has served as a member of the adjunct faculty of St. Joseph’s University, Philadelphia, Pa.


Rose Mary HoyRose Mary B. Hoy, P'82, RPh
Vice Chair
Board member Since 2013
BS, Philadelphia College of Pharmacy 
Retired, Executive Director of Pharmacy and Distribution, Merck &Co.

Hoy graduated from the Philadelphia College of Pharmacy (now University of the Sciences in Philadelphia) with a degree in Pharmacy and also earned a Business Certificate from the Wharton School. She maintains her pharmacy license in Pennsylvania, and has practiced in hospital and community pharmacy. Shortly after graduating, Hoy joined Merck & Co., Inc. where she enjoyed a successful 35 year career. Her career spanned four divisions: Operations, Marketing, Merck Medco/Managed Care, Sales/Account Management. Major accomplishments include: Charter member of Merck Vaccine Division, cementing the company’s strategic focus on public health; led the division’s response to measles epidemic, successfully implementing new CDC guidelines with launch of Merck’s first-ever DTC campaign; established and led innovative sales team dedicated to retail pharmacy customer base. Advanced Merck’s legacy in public health by supporting activities to train and advocate for pharmacist administered vaccinations, advancing the role of pharmacists in delivery of healthcare services; directed and implemented modified supply chain strategies, resulting in significant efficiency enhancements for Merck and for customers, and changing the industry business model; and sponsored cross divisional initiative to re-design labels for Merck products, enhancing patient safety by reducing potential for dispensing errors. Published project design and results, with recognition received from FDA and external patient advocacy groups. Hoy is married to Michael R. Hoy, PhD and they have two children, Jennifer and Daniel. In her retirement, Hoy focuses her energies in the following areas: healthcare advocacy, church ministry, reading, home decorating, world travel and serving on the Board of Trustees for the University of the Sciences in Philadelphia.


Jay BornemanJohn P. (Jay) Borneman, MBA, PhD'07
Board Member Since 2020
St. Joseph’s University; PhD, Misher College of Arts and Sciences
Chairman and Chief Executive Officer of Standard Homeopathic Company and Hyland’s Inc.

Dr. Borneman is Chairman and Chief Executive Officer of Standard Homeopathic Company and Hyland’s Inc., where he has been since 1987. He also serves on the boards of Apparo LLC, a developer of novel plant-based extraction technologies, the Homeopathic Pharmacopeia of the United States as its Chairman, and the Consumer Healthcare Products Association as its Audit Committee Chair. Borneman is an emeritus director of The Southwest College of Naturopathic Medicine and Health Sciences, and The National Center for Homeopathy. He also serves as a member of the Board of Visitors of Philadelphia College of Pharmacy.  Dr. Borneman earned bachelor’s and master’s degrees in chemistry from St. Joseph’s University as well as an MBA with a concentration in finance from the University. He subsequently earned his Ph.D. from the Department of Health Policy and Public Health at USciences. His research interests are in the health policy considerations of healthcare access and Complementary and Alternative Medicine (CAM).


Carla Hendricks

Carla D. Hendricks, CPA, MS
Board Member Since 2016 
BS, La Salle University; MS, Widener University
Vice President, Head of Tax at Dow Jones

Hendricks has spent her career as a tax professional with U.S. and international responsibilities helping companies implement tax strategies and analyze complex situations. She has a successful and extensive track record of working with senior management while managing various tax and accounting related projects. Since January 2015, Hendricks has been with Dow Jones/News Corp serving as VP Head of Tax at Dow Jones since 2018. Prior to that role, she was a senior director of tax planning and reporting at Tyco International, Inc. in Princeton, N.J., where she began in 2005, helping senior leadership to manage various national and international tax planning projects, developing global tax planning strategies, and managing cross-functional teams. Hendricks joined Tyco after eight years with Unisys Corporation. Other stops on her career path include ARCO Chemical Company, Basell Polyolefins, and Ernst & Young. She has been a certified public account since 1985.


Richard HowardRichard Howard
Board Member Since 2007
BS, University of Pennsylvania
Retired, CEO and Investor, Advanced Pharmacy Services, Inc.

Howard's business career includes 12 years in commercial banking and 19 years in healthcare management. Howard served on the USciences board of trustees from 1995 to 2004 and rejoined the board in 2007, where he has been a member of the Finance and Investment Committee and Executive Committee. Since 2009, Howard has served as CEO and investor at Advanced Pharmacy Services, Inc., in Houston, Texas. A private equity-financed institutional pharmacy services company, Advanced Pharmacy Services provides prescription medications to skilled nursing centers. A graduate of the Wharton School at the University of Pennsylvania in 1971 with a degree in corporate finance, Howard began his career at Fidelity Bank where he was a vice president. He went on to tenures at Health Group Care Centers, Inc., Equibank, Genesis Health Ventures, Inc., and Flagship Global Health, Inc.


Cedric JonesRev. Cedric H. Jones, Jr. MBA, MDiv, DMin, PhD
Board Member Since 2013
BS, Massachusetts Institute of Technology; MBA, PhD, University of Pennsylvania; MDiv, Boston University; DMin, Lutheran Theological Seminary of Philadelphia
Senior Pastor, Mount Zion Baptist Church

Rev. Jones serves as the 4th Pastor since Mount Zion Baptist Church was founded in 1914. As the Chief Ministry Officer and Senior Pastor, responsibilities include leading the congregation into greater Christian discipleship individually and collectively, ministering to the holistic needs of the congregation and community, and fostering broad based stewardship accountability to ensure a thriving body of Christ. Chair of a Community Development Corporation that has built a $13 million living residence for low-income seniors. Guest preacher/revivalist at A.M.E., Anglican and Baptist churches in Pennsylvania, New Jersey, Massachusetts, Ohio, Washington DC, Virginia, North Carolina and Barcelona-Spain. Previous pastoral ministry for over 20 years at churches in Cincinnati, Boston and Philadelphia. Seminary course instructor, featured lecturer, and workshop leader on Leadership, Social Entrepreneurship and Education. Previously, he spent 20 years at Johnson & Johnson where he held a variety of positions including in management, marketing, sales and business development building brands and developing leaders. Prior to that work, Rev. Jones was co-founder and vice president of TechSoft Systems, an information systems and software firm serving Fortune 500 clients, and at Procter & Gamble as a product development engineer.


Robin KeyakRobin L. Keyack, P'81, BSc, RPh
Board Member Since 2014
BS, Philadelphia College of Pharmacy
Assistant Vice President, Ambulatory & Surgical Services, Shore Medical Center

Keyack has devoted her career to the practice of pharmacy in the acute care hospital setting, having served patients at Shore Medical Center since March 2011. Previously, Keyack worked at Virtua for 18 years where she held various positions within the organization including Assistant Vice President of Pharmacy Services, Clinical Resource Manager and Information Systems Director. She began her career as a staff pharmacist at our nation’s first hospital, Pennsylvania Hospital, becoming the Assistant Director of Pharmacy in 1984. Keyack has devoted much of her hospital pharmacy career to medication safety initiatives and has been influential in the implementation of numerous programs and strategies including Smart Infusion Pumps and Electronic Health Record projects. She has also successfully implemented a comprehensive clinical pharmacy program, aligned with quality and patient safety, based on evidence based pharmacy models and holds a Green Belt in Six Sigma methodology. In the Delaware Valley, Keyack is considered to be a leader in hospital pharmacy management and has served as co-chair of the NJ Quality Improvement Advisory Committee.  She is also on the Board of Trustees for Samaritan Healthcare and Hospice of Mt. Laurel, NJ.


Ed MercadanteEdgardo (Ed) A. Mercadante, P’79, RPh, HonDSc
Board Member Since 2020
BS, HonDSc, Philadelphia College of Pharmacy
Founder and Chief Executive Officer, MediTelecare

Dr. Mercadante is the founder and CEO of MediTelecare, a dynamic telehealth/ telemedicine company delivering healthcare and behavioral healthcare to patients in long-term care facilities, rural hospitals, and community health centers. Prior to founding MediTelecare, he served as the CEO of MedOptions, the national leader in Behavioral Care to the Long-Term Care industry, and was founder/investor in PursueCare, a telehealth addiction treatment platform. He is also independently involved in Pharmacy and other health-related businesses. In addition to his BS degree in pharmacy from Philadelphia College of Pharmacy, Dr. Mercadante has pursued advanced studies in healthcare and Pharmacy Administration at the University of South Carolina and is a registered pharmacist in numerous states. He was awarded an honorary doctor of science degree from USciences at Founders’ Day in 2017.


Michael SofiaMichael J. Sofia, PhD
Board Member Since 2016
BA, Cornell University; PhD, University of Illinois at Urbana-Champaign
Chief Scientific Officer, Arbutus Biopharma, Inc.

Dr. Sofia is currently Chief Scientific Officer and co-founder of Arbutus Biopharma, Inc. a company focused on the discovery and development of therapies to treat hepatitis B and coronavirus infections. He also holds a professorship at the Baruch S. Blumberg Institute and an Adjunct Professorship at the Drexel University School of Medicine.  Mike has spent his career in pharmaceutical research and development working to deliver lifesaving drugs to patients with unmet medical needs. He received his BA for Cornell University, PhD from the University of Illinois and was a postdoctoral fellow at Columbia University.  He is recognized for his work on the discovery and development of the drug sofosbuvir as a cure for HCV.  His work has been recognized with numerous awards that include the Economist Magazine’s 2015 Innovation Award in Biosciences, the Lasker-Debakey Award in Clinical Medical Research and the Cameron Prize for Therapeutics


Sam WetherillSamuel R. Wetherill IV, P'97, PharmD, MHA, MPS-SCM
Board Member Since 2019
BS, Philadelphia College of Pharmacy; PharmD, University of Florida; MHA, Simmons College; MPS, Penn State University
Vice President, Pharmacy Services, ChristianaCare Health System

Dr. Wetherill is currently the Vice President, Pharmacy Services for ChristianaCare Health System and is retired from the US Army Reserves with more than 22 years of experience in a variety of operational pharmacy and management roles. Prior to his current position, he served as the Director of Pharmacy Supply Chain/Automation and as the Director of Inpatient Operations at the ChristianaCare Wilmington Campus. Dr. Wetherill also serves as a preceptor for pharmacy students at Thomas Jefferson University and USciences. He remains an active member of the American Society of Health-System Pharmacists. Dr. Wetherill is a decorated military officer. He was stationed in Germany, Bosnia, Kosovo, and Ft. Benning Georgia, eventually rising to the rank of Lieutenant Colonel.  During his military career, Dr. Wetherill received a variety of medals and service ribbons. After his active duty time, Dr. Wetherill stayed active in the US Army Reserves. His last position prior to retirement was at Ft. Dix, NJ, where he spent 5 years as a Command and General Staff College Instructor. He was named US Army Reserve Pharmacist of the Year in 2013.

Secretary and General Counsel

Odessa P. JacksonOdessa P. Jackson, Esq.
General Counsel, Chief Compliance Officer, and Secretary to the Board of Trustees
 
 

Administration

University Officers 

Paul KatzPaul Katz, MD
President
president@usciences.edu

 

Jill M Baren Jill M. Baren, MD
Provost and Vice President of Academic Affairs
jbaren@usciences.edu 

 

David FordeDavid L. Forde, Jr., Esq.
Vice President for Community and Government Affairs
d.forde@usciences.edu

 

Ron KishenRonald Kishen
Vice President for USciences Online
rkishen@usciences.edu

 

Ross RadishRoss W. Radish, JD
Vice President for Student Affairs and Dean of Students
r.radish@usciences.edu

 

Robb M. RuddRob Rudd, MA
Vice President for Institutional Advancement
r.rudd@usciences.edu

 

Patti VanstonPatricia Vanston, EdD
Vice President for Business Development and Enrollment Management
p.vanston@usciences.edu 

 

Valerie WeilValerie Weil, MD, FACP
(TREASURER)
Chief Financial and Operating Officer
v.weil@usciences.edu

Contact:

Beth Pilipzeck

Address:

Office Location: Griffith Hall, Room 104
University of the Sciences
600 South 43rd Street
Philadelphia, PA 19104-4495

Phone:

215-596-8970

Email:

president@usciences.edu